สหภาพยุโรป -
ไอซ์แลนด์ -
EMA (European Medicines Agency)
tolucombi
krka, d.d., novo mesto - telmisartan, hydrochlorothiazide - háþrýstingur - þess og þvagræsilyf - Áhrif á fastur-skammt samsetning (80 mg skipt um 25 mg sýnt fram á að hjá) er ætlað í fullorðnir sem blóðþrýstingur er ekki nægilega stjórn á Áhrif á 80 mg/12. 5 mg (80 mg telmisartan / 12. 5 mg hýdróklórtíazíð) eða fullorðnir sem hafa áður verið stöðugir á telmisartani og hýdróklórtíazíði, gefnum sérstaklega.
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
hypotron tafla 10 mg
brancaster pharma ireland ltd. - midodrinum hýdróklóríð - tafla - 10 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
hypotron tafla 2,5 mg
brancaster pharma ireland ltd. - midodrinum hýdróklóríð - tafla - 2,5 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
hypotron tafla 5 mg
brancaster pharma ireland ltd. - midodrinum hýdróklóríð - tafla - 5 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
levaxin tafla 0,05 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,05 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
levaxin tafla 0,1 mg
orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,1 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
ambisome liposomal innrennslisstofn, ördreifa 50 mg
gilead sciences ireland uc* - amphotericinum b inn - innrennslisstofn, ördreifa - 50 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
hydromed tafla 25 mg
medilink a/s - hydrochlorothiazidum inn - tafla - 25 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 95 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 95 mg
ไอซ์แลนด์ -
ไอซ์แลนด์ -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 47,5 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 47,5 mg